−0.30 TWD
124.62 M TWD
793.77 M TWD
About GENEFERM BIOTECHNOLOGY CO LTD
Sector
CEO
Chin Te Chin
Headquarters
Tainan
Website
Founded
1999
ISIN
TW0001796001
FIGI
BBG00DDKB1V3
GeneFerm Biotechnology Co., Ltd. engages in the manufacture and sale of health food and supplement. It specializes in microbial fermentation, strains screening & recovery and purification technology. The company's products include nattokinase, red yeast rice, medicinal fungi, probiotics, herbal extracts, and animal derived products such as marine collagen peptide and d-glucosamine powder. GeneFerm Biotechnology was founded on July 17, 1999 and is headquartered in Tainan, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1796 is 46.70 TWD — it has increased by 1.86% in the past 24 hours. Watch GENEFERM BIOTECHNOLOGY CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GENEFERM BIOTECHNOLOGY CO LTD stocks are traded under the ticker 1796.
1796 stock has fallen by −1.48% compared to the previous week, the month change is a −7.47% fall, over the last year GENEFERM BIOTECHNOLOGY CO LTD has showed a −37.90% decrease.
1796 reached its all-time high on May 15, 2023 with the price of 158.50 TWD, and its all-time low was 18.50 TWD and was reached on Mar 23, 2020. View more price dynamics on 1796 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1796 stock is 2.49% volatile and has beta coefficient of 0.59. Track GENEFERM BIOTECHNOLOGY CO LTD stock price on the chart and check out the list of the most volatile stocks — is GENEFERM BIOTECHNOLOGY CO LTD there?
Today GENEFERM BIOTECHNOLOGY CO LTD has the market capitalization of 1.93 B, it has decreased by −3.18% over the last week.
Yes, you can track GENEFERM BIOTECHNOLOGY CO LTD financials in yearly and quarterly reports right on TradingView.
1796 net income for the last quarter is −11.24 M TWD, while the quarter before that showed −6.03 M TWD of net income which accounts for −86.42% change. Track more GENEFERM BIOTECHNOLOGY CO LTD financial stats to get the full picture.
Yes, 1796 dividends are paid annually. The last dividend per share was 2.00 TWD. As of today, Dividend Yield (TTM)% is 4.31%. Tracking GENEFERM BIOTECHNOLOGY CO LTD dividends might help you take more informed decisions.
GENEFERM BIOTECHNOLOGY CO LTD dividend yield was 2.68% in 2023, and payout ratio reached 66.54%. The year before the numbers were 2.24% and 66.37% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENEFERM BIOTECHNOLOGY CO LTD EBITDA is 69.01 M TWD, and current EBITDA margin is 28.60%. See more stats in GENEFERM BIOTECHNOLOGY CO LTD financial statements.
Like other stocks, 1796 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENEFERM BIOTECHNOLOGY CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENEFERM BIOTECHNOLOGY CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENEFERM BIOTECHNOLOGY CO LTD stock shows the sell signal. See more of GENEFERM BIOTECHNOLOGY CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.